BHCM
TMO icon

Boulder Hill Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Boulder Hill Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-800
Closed -$417K – 144
2023
Q2 		$417K Buy
+800
New +$432K 0.8% 33
2022
Q3 		– Sell
-800
Closed -$435K – 199
2022
Q2 		$435K Buy
+800
New +$440K 0.5% 67

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boulder Hill Capital Management's TMO Position: Q3 2023 in Review

Boulder Hill Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 800 shares — an estimated $417K sold.

Boulder Hill Capital Management first reported a position in TMO in Q2 2022 and held it in 2 quarters. The position peaked at $435K in Q2 2022. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Boulder Hill Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 800 Thermo Fisher Scientific shares in Q3 2023, an estimated $417K.
  • Boulder Hill Capital Management first reported a position in Thermo Fisher Scientific in Q2 2022 and held it in 2 quarters.
  • Boulder Hill Capital Management's Thermo Fisher Scientific position peaked at $435K in Q2 2022.
  • 2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Boulder Hill Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.